دكساميسين
Country: Iżrael
Lingwa: Għarbi
Sors: Ministry of Health
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
DEXAMETHASONE AS SODIUM PHOSPHATE 1 MG/ML; NEOMYCIN AS SULFATE 5 MG/ML
Disponibbli minn:
TEVA PHARMACEUTICAL INDUST.LTD
Kodiċi ATC:
S03AA01
Għamla farmaċewtika:
OPHTHALMIC SOLUTION
Rotta amministrattiva:
OCULAR
Manifatturat minn:
TEVA PHARMACEUTICAL INDUSTRIES LTD
Grupp terapewtiku:
NEOMYCIN
Indikazzjonijiet terapewtiċi:
Steroid-responsive allergic and inflammatory disorders of the anterior segments of the eye (conjunctival, corneal, or uveal tract inflammation) or mechanical, chemical or thermal trauma where bacterial infection or a risk of bacterial ocular infection exists.
Data ta 'l-awtorizzazzjoni:
2010-10-01
